Vorinostat Completed Phase 2 Trials for Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) / Adult Acute Promyelocytic Leukemia (M3) / Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) / Adult Acute Monocytic Leukemia (M5b) / Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) / Adult Acute Myeloblastic Leukemia With Maturation (M2) / Adult Acute Monoblastic Leukemia (M5a) / Adult Acute Erythroid Leukemia (M6) / Untreated Adult Acute Myeloid Leukemia / Recurrent Adult Acute Myeloid Leukemia / Adult Acute Myelomonocytic Leukemia (M4) / Adult Acute Megakaryoblastic Leukemia (M7) / Refractory Cytopenia With Multilineage Dysplasia / Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities / Adult Acute Myeloid Leukemia With T(15;17)(q22;q12) / Adult Acute Minimally Differentiated Myeloid Leukemia (M0) / Secondary Acute Myeloid Leukemia (Secondary AML, sAML) / Adult Acute Myeloblastic Leukemia Without Maturation (M1) Treatment